NCT04778800 2021-08-31
A Dose Exploration Study of Almonertinib for EGFRm NSCLC Patients With Brain/Leptomeningeal Metastasis (ARTISTRY)
Henan Cancer Hospital
Phase NA Unknown
Henan Cancer Hospital
Taipei Veterans General Hospital, Taiwan
Sheba Medical Center
Tel-Aviv Sourasky Medical Center
Tel-Aviv Sourasky Medical Center